Novavax Inc (NASDAQ:NVAX)

1.36
Delayed Data
As of Jul 16
 0.00 / 0.00%
Today’s Change
0.91
Today|||52-Week Range
2.75
+9.68%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close1.36
Today’s open1.35
Day’s range1.34 - 1.37
Volume2,570,996
Average volume (3 months)5,573,728
Market cap$645.0M
Data as of 4:00pm ET, 07/16/2018

Growth & Valuation

Earnings growth (last year)+38.83%
Earnings growth (this year)+16.03%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+103.06%
P/E ratioNM
Price/Sales11.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.11-5.02%
EDGEEdge Therapeutics In...0.000.00%
BTXBioTime Inc-0.05-2.15%
RIGLRigel Pharmaceutical...-0.08-2.81%
Data as of 8:00pm ET, 07/16/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$31.2M
Annual profit (last year)-$183.8M
Net profit margin-589.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Senior VP-
Global Manufacturing Operations
Timothy Jon Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts